Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,181 to 1,200 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeted Mass Spectrometry Enables Multiplexed Quantification of Immunomodulatory Proteins in Clinical Biospecimens. | Front Immunol | 2021 | 34858420 | PubTator, text mining | PubMed |
| Perfect adaptation of CD8+ T cell responses to constant antigen input over a wide range of affinities is overcome by costimulation. | Sci Signal | 2021 | 34855472 | PubTator, text mining | PubMed |
| piggyBac system to co-express NKG2D CAR and IL-15 to augment the in vivo persistence and anti-AML activity of human peripheral blood NK cells. | Mol Ther Methods Clin Dev | 2021 | 34853803 | PubTator, text mining | PubMed |
| A Transcription Factor-Based Risk Model for Predicting the Prognosis of Prostate Cancer and Potential Therapeutic Drugs. | Evid Based Complement Alternat Med | 2021 | 34853602 | PubTator, text mining | PubMed |
| T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab-based therapy. | Clin Transl Med | 2021 | 34845849 | PubTator, text mining | PubMed |
| The multicellular signalling network of ovarian cancer metastases. | Clin Transl Med | 2021 | 34841720 | PubTator, text mining | PubMed |
| Histology and Immunohistochemistry of Radial Arteries Are Suggestive of an Interaction between Calcification and Early Atherosclerotic Lesions in Chronic Kidney Disease. | Medicina (Kaunas) | 2021 | 34833374 | PubTator, text mining | PubMed |
| The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma. | Cancers (Basel) | 2021 | 34830842 | PubTator, text mining | PubMed |
| Roles of OX40 and OX40 Ligand in Mycosis Fungoides and Sézary Syndrome. | Int J Mol Sci | 2021 | 34830466 | PubTator, text mining | PubMed |
| Highlights of Immunomodulation in Salmonella-Based Cancer Therapy. | Biomedicines | 2021 | 34829795 | PubTator, text mining | PubMed |
| Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL). | Diagnostics (Basel) | 2021 | 34829391 | PubTator, text mining | PubMed |
| Production of human CAR-NK cells with lentiviral vectors and functional assessment in vitro. | STAR Protoc | 2021 | 34825217 | PubTator, text mining | PubMed |
| Born to survive: how cancer cells resist CAR T cell therapy. | J Hematol Oncol | 2021 | 34809678 | PubTator, text mining | PubMed |
| Quantitative contributions of TNF receptor superfamily members to CD8+ T-cell responses. | Mol Syst Biol | 2021 | 34806839 | PubTator, text mining | PubMed |
| Enhancing Natural Killer Cell Targeting of Pediatric Sarcoma. | Front Immunol | 2021 | 34804076 | PubTator, text mining | PubMed |
| Cross Talk Between Macrophages and Cancer Cells in the Bone Metastatic Environment. | Front Endocrinol (Lausanne) | 2021 | 34803925 | PubTator, text mining | PubMed |
| Systematic Analysis Uncovers Associations of PGK1 with Prognosis and Immunological Characteristics in Breast Cancer. | Dis Markers | 2021 | 34790279 | PubTator, text mining | PubMed |
| Dysfunctional BTN3A together with deregulated immune checkpoints and type I/II IFN dictate defective interplay between pDCs and γδ T cells in melanoma patients, which impacts clinical outcomes. | Clin Transl Immunology | 2021 | 34786191 | PubTator, text mining | PubMed |
| The possible role of SRMS in colorectal cancer by bioinformatics analysis. | World J Surg Oncol | 2021 | 34781983 | PubTator, text mining | PubMed |
| Increased expression of PSME2 is associated with clear cell renal cell carcinoma invasion by regulating BNIP3‑mediated autophagy. | Int J Oncol | 2021 | 34779489 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=60